jump to content

Fachbereich Veterinärmedizin


Service-Navigation

    Publication Database

    Mitotic activity:
    a systematic literature review of the assessment methodology and prognostic value in canine tumors (2024)

    Art
    Zeitschriftenartikel / wissenschaftlicher Beitrag
    Autoren
    Bertram, Christof A.
    Donovan, Taryn A.
    Bartel, Alexander (WE 16)
    Quelle
    Veterinary pathology : an internat. journal of natural and experimental disease in animals
    Bandzählung: 61
    Heftzählung: 5
    Seiten: 752 – 764
    ISSN: 0300-9858
    Sprache
    Englisch
    Verweise
    URL (Volltext): https://journals.sagepub.com/doi/10.1177/03009858241239565
    DOI: 10.1177/03009858241239565
    Pubmed: 38533804
    Kontakt
    Institut für Veterinär-Epidemiologie und Biometrie

    Königsweg 67
    14163 Berlin
    +49 30 838 56034
    epi@vetmed.fu-berlin.de

    Abstract / Zusammenfassung

    One of the most relevant prognostic indices for tumors is cellular proliferation, which is most commonly measured by the mitotic activity in routine tumor sections. The goal of this systematic review was to analyze the methods and prognostic relevance of histologically measuring mitotic activity that have been reported for canine tumors in the literature. A total of 137 articles that correlated the mitotic activity in canine tumors with patient outcome were identified through a systematic (PubMed and Scopus) and nonsystematic (Google Scholar) literature search and eligibility screening process. Mitotic activity methods encompassed the mitotic count (MC, number of mitotic figures per tumor area) in 126 studies, presumably the MC (method not specified) in 6 studies, and the mitotic index (MI, number of mitotic figures per number of tumor cells) in 5 studies. A particularly high risk of bias was identified based on the available details of the MC methods and statistical analyses, which often did not quantify the prognostic discriminative ability of the MC and only reported P values. A significant association of the MC with survival was found in 72 of 109 (66%) studies. However, survival was evaluated by at least 3 studies in only 7 tumor types/groups, of which a prognostic relevance is apparent for mast cell tumors of the skin, cutaneous melanoma, and soft tissue tumor of the skin and subcutis. None of the studies using the MI found a prognostic relevance. This review highlights the need for more studies with standardized methods and appropriate analysis of the discriminative ability to prove the prognostic value of the MC and MI in various tumor types. Future studies are needed to evaluate the influence of the performance of individual pathologists on the appropriateness of prognostic thresholds and investigate methods to improve interobserver reproducibility.